GlassScriptPhysician profile
Harpreet Grewal
NPI 1700842697
$9,769.12
in general payments reported to CMS, 2019-2025
45 companies · $773 in 2025
The $773 reported for 2025 was more than what 80% of Adult Medicine providers received nationally (typical 2025 total: $127).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,662 · 2020: $1,826 · 2021: $2,178 · 2022: $1,292 · 2023: $929 · 2024: $1,109 · 2025: $773.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,811.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,811.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,532.92 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Glaxosmithkline, LLC. | $695.34 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Amgen INC. | $671.97 | 2019-2025 | Evenity, Prolia |
| Novo Nordisk INC | $657.90 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Kowa Pharmaceuticals America, INC. | $539.22 | 2019-2025 | Zoryve |
| Pfizer INC. | $510.51 | 2019-2025 | |
| Lilly USA, LLC | $501.06 | 2019-2025 | Mounjaro, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $492.10 | 2019-2024 | Jardiance |
| Abbvie INC. | $398.33 | 2021-2024 | |
| Merck Sharp & Dohme LLC | $396.37 | 2019-2025 | Gardasil 9, Capvaxive, Gardasil |
| Sanofi-Aventis U.S. LLC | $366.84 | 2019-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $359.97 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $351.40 | 2019-2022 | |
| Abbott Laboratories | $260.22 | 2019-2025 | Freestyle Libre 3 |
| Astellas Pharma US INC | $257.01 | 2020-2025 | Veozah |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harpreet Grewal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.